Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Liraglutide MeSH Descriptor Data 2026


MeSH Heading
Liraglutide
Tree Number(s)
D06.472.317.680.500.500.500
Unique ID
D000069450
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069450
Scope Note
An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.
Entry Term(s)
NN 2211
NN-2211
NN2211
Saxenda
Victoza
Pharm Action
Incretins
Glucagon-Like Peptide-1 Receptor Agonists
Registry Numbers
839I73S42A
0
Related Numbers
204656-20-2
Public MeSH Note
2016; LIRAGLUTIDE was indexed under GLUCAGON-LIKE PEPTIDE 1 2005-2015; and under GLUCAGON 2001-2005
History Note
2016 (2001)
Date Introduced
2016/01/01
Last Updated
2023/05/31
Liraglutide Preferred
NN 2211 Narrower
Victoza Narrower
Saxenda Narrower
page delivered in 0.148s